Abstract
One of the biggest challenges in pharmaceutical development is finding drug candidates with a desired activity or efficacy balanced with low toxicity or side-effects. Despite the enormous effort and cost required to get drugs to market, numerous drugs have been abandoned due to unanticipated, untoward effects. Clearly, technologies are needed that can identify safe and effective pharmaceutical candidates early in the drug pipeline. Our laboratory has developed a computer modeling technology that can be used to screen small-molecule ligands for certain desired activities as well as certain toxicities. The technology utilizes modeling of the intercalation of molecules into DNA to create efficacy and toxicity search engines and is grounded by two fundamental observations. First, intercalation has been shown to be integral in the action of drugs that act in concert with nuclear enzymes, e.g., topoisomerases. Second, evidence is mounting that intercalation facilitated by nuclear receptors bound to natural ligands is a critical part of their genomic mode of action. To date, two classes of search engines have been created, i.e., those that can be used to identify: (1) efficacious molecules, e.g., antibiotics, estrogens, androgens, glucocorticoids, thyroid drugs, antidepressants, antihistamines, and sedatives, and (2) toxic molecules, e.g., certain carcinogens and genotoxins. Here, we describe the creation of two prototype search engines (the estrogen efficacy and arene oxide genotoxicity search engines) and illustrative results of searches of three-dimensional databases. Of particular interest is the specificity of the search engines and their capacity to identify widely different, and in some cases obscure, structures having the same activities. Taken as a whole, future drug discovery research is likely to focus on methods to assess DNA intercalation as a salient feature of selecting safe and effective drug candidates.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00044-007-9046-3/MediaObjects/44_2007_9046_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00044-007-9046-3/MediaObjects/44_2007_9046_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00044-007-9046-3/MediaObjects/44_2007_9046_Fig3_HTML.gif)
Similar content being viewed by others
References
Antony S, et al. (2006) Bisindenoisoquinoline Bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity. Mol Pharmacol 70:1109–1120
Denny WA, Baguley BC (2003) Dual topoisomerase I/II inhibitors in cancer therapy. Curr Top Med Chem 3:339–353
Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889–895
Flores LV, et al. (2006) Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase IIalpha promoter. Chem Bio Chem 7:1722–1729
Gordon-Gray CG, Wells RB (1974) The sencio alkaloids. Structure and absolute configuration of swazine. J Chem Soc [Perkin 1] 1556–1561
Hendry LB, Witham FH, Chapman OL (1977) Gene regulation: the involvement of steroeochemcal recognition in DNA-small molecule interactions. Perspect Biol Med 21:120–130
Hendry LB (1988) Stereochemical complementary of DNA and steroid agonists and antagonists. J Steroid Biochem 31:493–523
Hendry LB, Mahesh VB (1995) A putative step in steroid hormone action involves insertion of steroid ligands into DNA facilitated by receptor proteins. J Steroid Biochem Mol Biol 55:173–183
Hendry LB, Bransome ED Jr, Mahesh VB (1998) J Steroid Biochem Mol Biol 65:75–89
Horeau A, Jacques J (1947) Structure moleculaire et activite ostrogene: acides hydroxynapthylpropioniques substitutes. C R Acad Sci 234:862–864
Huggins C, Yang NC (1962) Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cure of breast cancer. Science 137:257–262
Kupchan S, Maruyama M J (1971) Reductive elimination of epoxides to olefins with zinc-copper couple. J Org Chem 36:1187–1191
Ling H, et al. (2004) Crystal structure of a benzo[a]pyrene diol epoxide adduct in a ternary complex with a DNA polymerase. Proc Natl Acad Sci 101:2265–2269
Lerman LS (1961) Structural considerations in interaction of DNA and acridines. J Mol Biol 3:18–30
Mahesh VB, et al. (2001) Gene based pharmacophores for drug design. Med Chem Res 10:440–455
Mahesh VB, et al. (2004) New technology for drug discovery based upon insertion of ligands into gene sequences by nuclear receptor proteins, Med Chem Res 13:497–508
McChesney JD, Kabra PM, Fraher PJ (1979) Simple analogs of the toxin callicarpone. Pharm Sci 68:1116–1120
Neault JF, Tajmir-Riahi HA (1996) Diethylstilbestrol-DNA interaction studies by Fourier transform Raman spectroscopy. J Biol Chem 271:8140–8143
Porter LA (1967) Picrotoxin and related substances. Chem Rev 67:441–464
Richardson KE, Hagler WM, Mirocha CJJ (1985) Production of zearalenone, α- and β-zearalenol, and α- and β-zearalanol by Fusarium Spp. in rice cultures. Agric Food Chem 33:862–866
Snyder RD, Gilles PJ (2002) Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavanoids in Chinese hamster V79 cells. Envion Mol Mutagen 2002 40:266–276
Snyder RD, Ewing D, Hendry LB (2006) DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays. Mutat Res 609:47–59
Staker BL, et al. (2005) Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J Med Chem 48:2336–2345
Tsai MJ, O’Malley WO (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451–486
Wei H, et al. (1998) DNA structural integrity and base composition affect ultraviolet light-induced oxidative DNA damage. Biochemistry 37:6485–6490
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahesh, V.B., Ewing, D.E. & Hendry, L.B. Assessing activity and toxicity of drugs in silico based on DNA structure. Med Chem Res 17, 159–168 (2008). https://doi.org/10.1007/s00044-007-9046-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-007-9046-3